National Health Investors, Inc. (NYSE:NHI) Sees Large Drop in Short Interest

National Health Investors, Inc. (NYSE:NHI) saw a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 2,094,689 shares, a decrease of 44.0% from the June 30th total of 3,740,952 shares. Currently, 4.4% of the company’s shares are short sold. Based on an average trading volume of 441,598 shares, the days-to-cover ratio is presently 4.7 days.

National Health Investors Trading Down 3.0%

NYSE NHI traded down $2.37 during trading on Thursday, hitting $75.92. The company had a trading volume of 357,110 shares, compared to its average volume of 394,840. The company’s fifty day moving average is $75.13 and its 200-day moving average is $79.76. National Health Investors has a one year low of $67.94 and a one year high of $91.38. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market cap of $3.68 billion, a price-to-earnings ratio of 24.49, a price-to-earnings-growth ratio of 3.51 and a beta of 0.51.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Tuesday, June 30th. National Health Investors’s dividend payout ratio is presently 118.71%.

Insider Activity

In related news, CEO D. Eric Mendelsohn acquired 1,500 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in NHI. International Assets Investment Management LLC purchased a new position in shares of National Health Investors in the 4th quarter valued at approximately $27,000. EverSource Wealth Advisors LLC lifted its position in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC bought a new stake in shares of National Health Investors during the 4th quarter valued at $33,000. GAMMA Investing LLC boosted its holdings in shares of National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 136 shares in the last quarter. Finally, Key Capital Management INC purchased a new stake in shares of National Health Investors in the 4th quarter worth about $47,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Wells Fargo & Company decreased their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. BMO Capital Markets cut their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Deutsche Bank Aktiengesellschaft reduced their price target on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Weiss Ratings lowered National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Finally, Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, National Health Investors has a consensus rating of “Moderate Buy” and an average price target of $83.86.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.